Obesity management approaches
About this episode
Ole Schmiedel discusses the new weight loss drug Mounjaro, its mechanism of action, and its implications for obesity management.
In this episode Ole Schmiedel discusses Mounjaro, a new weight loss drug, with a focus on its mechanism of action, practical use, side effects, nutritional considerations, and long-term safety. The conversation provides insights into how Mounjaro differs from previous GLP-1 receptor agonists, expected weight loss outcomes, and the importance of monitoring patients while on the medication.
More episodes of Goodfellow Unit
- Familial Hyperlipidemia
- Refugee Health
- Sepsis
- Male genital skin conditions
- Haematology insights
- Older adults and medication management
Explore listener stats, chart rankings, contacts and more on the Goodfellow Unit podcast page.